Back to Search
MICHAEL HERSHFIELD, M.D.
M.D.
Rheumatology Physician
NPI: 1639251739Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
21274(NC)
Research & Publications (20)
Reassessing serum urate targets in the management of refractory gout: can you go too low?
PMID 19339924·Curr Opin Rheumatol·2009
6-review
New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
PMID 15580654·Eur J Immunol·2005
6-review
Genotype is an important determinant of phenotype in adenosine deaminase deficiency.
PMID 14499267·Curr Opin Immunol·2003
6-review
Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.
PMID 11316859·J Am Soc Nephrol·2001
7-preclinical
Purine nucleoside phosphorylase deficiency with fatal course in two sisters.
PMID 19657670·Eur J Pediatr·2010
5-case
Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient.
PMID 18952502·Clin Immunol·2009
5-case
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients.
PMID 18218852·Blood·2008
3-trial
In memoriam: J. Edwin Seegmiller, M.D. (1920-2006).
PMID 18600502·Nucleosides Nucleotides Nucleic Acids·2008
8-other
An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication.
PMID 18208442·Pediatr Transplant·2008
5-case
A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.
PMID 17680812·Eur J Haematol·2007
5-case
Uricase and other novel agents for the management of patients with treatment-failure gout.
PMID 17531181·Curr Rheumatol Rep·2007
6-review
Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
PMID 17328081·Arthritis Rheum·2007
3-trial
Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).
PMID 17300989·Clin Immunol·2007
5-case
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.
PMID 17185467·Blood·2007
4-observational
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.
PMID 16973956·Blood·2007
5-case
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
PMID 16356199·Arthritis Res Ther·2006
3-trial
Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
PMID 16112907·Clin Immunol·2005
8-other
Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients.
PMID 16276484·Eur J Immunol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4101 N ROXBORO ST
DURHAM, NC 27704 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1639251739
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile